Search filters

List of works by Federica Moschella

Administration of different antigenic forms of altered peptide ligands derived from HIV-1 RTase influences their effects on T helper cell activation

scientific article published on 01 January 2003

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

scientific article published in January 2009

Corrigendum to “MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68” [Vaccine 29 (2011) 3935–3944]

scholarly article published in Vaccine

Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy.

scientific article published on 12 June 2013

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells

scientific article published on 05 April 2018

Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

scientific article published on 03 December 2011

Exploiting dendritic cells in the development of cancer vaccines

scientific article published on 04 October 2013

Identification of tissue-restricted transcripts in human islets.

scientific article

In vitro immunization with a recombinant antigen carrying the HIV-1 RT248-262 determinant inserted at different locations results in altered TCRVB region usage.

scientific article published on September 1999

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

scientific article published on 2 May 2015

MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.

scientific article published on 8 April 2011

Modulation of TCR recognition of MHC class II/peptide by processed remote N- and C-terminal epitope extensions

scientific article published on 01 August 2000

Role of Interferon Regulatory Factor 1 in Governing Treg Depletion, Th1 Polarization, Inflammasome Activation and Antitumor Efficacy of Cyclophosphamide.

scientific article published on 4 October 2017

Shifting gene expression profiles during ex vivo culture of renal tumor cells: implications for cancer immunotherapy.

scientific article published on January 2003

The Janus face of cyclophosphamide: A sterile inflammatory response that potentiates cancer immunotherapy

scientific article published on 29 July 2013

The added value of type I interferons to cytotoxic treatments of cancer.

scientific article published on 19 June 2017

Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma

article

Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic use

scientific article

Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide

scientific article published on 28 March 2011